Physician profile
Doris Devries
NPI 1952582777
$2,952.57
in general payments reported to CMS, 2019-2025
20 companies · $916 in 2025
The $916 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $289 · 2023: $921 · 2024: $478 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,315.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $337.26 | 2023-2025 | Epclusa, Livdelzi |
| Genzyme Corporation | $318.70 | 2021-2024 | |
| Abbott Laboratories | $316.73 | 2023-2025 | Freestyle Libre 3, Proclaim |
| Novo Nordisk INC | $261.30 | 2021-2023 | |
| Inspire Medical Systems, INC. | $226.56 | 2023-2024 | Inspire |
| Abbvie INC. | $188.86 | 2024-2025 | |
| Madrigal Pharmaceuticals | $139.99 | 2025 | Rezdiffra |
| Coloplast Corp | $133.31 | 2023-2024 | Altis, Titan |
| Alexion Pharmaceuticals, INC. | $123.66 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $121.86 | 2025 | Saphnelo |
| Corcept Therapeutics | $113.35 | 2025 | Korlym |
| Emd Serono, INC. | $102.05 | 2024 | |
| Edwards Lifesciences Corporation | $89.89 | 2022 | |
| Scynexis, INC. | $85.97 | 2022 | |
| Sk Life Science, INC. | $85.35 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $85.09 | 2023 | Yupelri |
| Jazz Pharmaceuticals INC. | $77.88 | 2025 | |
| Biogen, INC. | $76.29 | 2023 | |
| Pfizer INC. | $40.27 | 2023 | |
| Nevro Corp. | $28.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doris Devries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.